BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies Revenue

In the year 2023, BioRestorative Therapies had annual revenue of $145.80K with 21.70% growth. Revenue in the quarter ending December 31, 2023 was $19.30K with 421.62% year-over-year growth.

• Revenue (ttm): $145.80K
• Revenue Growth: +21.70%
• P/S Ratio: 63.38
• Revenue / Employee: $13,255
• Employees: 11
• Market Cap: 9.24M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	145.80K	26.00K	21.70%
Dec 31, 2022	119.80K	73.80K	160.43%
Dec 31, 2021	46.00K	-31.00K	-40.26%
Dec 31, 2020	77.00K	-53.00K	-40.77%
Dec 31, 2019	130.00K	19.00K	17.12%
Dec 31, 2018	111.00K	30.00K	37.04%
Dec 31, 2017	81.00K	44.65K	122.80%
Dec 31, 2016	36.36K	-592.56K	-94.22%
Dec 31, 2015	628.92K	212.92K	51.18%
Dec 31, 2014	416.00K	414.32K	24,661.67%
Dec 31, 2013	1.68K	-13.91K	-89.22%
Dec 31, 2012	15.59K	-	-
Dec 31, 2011	0	-	-
Dec 31, 2010	0	-	-
Dec 31, 2009	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.